Sfoglia per Titolo
Boron Reagents and Catalysts for the Functionalization of Strained Heterocycles
2021-01-01 Pineschi, M.
Boron toxicity in higher plants: an update
2019-01-01 Landi, M.; Margaritopoulou, T.; Papadakis, I. E.; Araniti, F.
Boron Trifluoride-Promoted Activation of Water by Bis(tricyclohexylphosphine)palladium(0).
1988-01-01 DI BUGNO, C; Leoni, Piero; Pasquali, Marco
BOROND, Addressing Boron relevant accidents in PWR and VVER-1000 Nuclear Reactors
2009-01-01 Pla, P; Parisi, C; D'Auria, FRANCESCO SAVERIO
Boronic Acids in the Three-Component Synthesis of Carbon-Substituted Cyclopentadienyl Tricarbonyl Rhenium Complexes
1998-01-01 Minutolo, Filippo; J. A., Katzenellenbogen
Borrowing strength over space in small area estimation using M-quantile geographically weighted models
2008-01-01 Tzavidis, N; Salvati, Nicola
«Borrowing the Dean’s Whip»: Baretti lettore di Jonathan Swift
2022-01-01 Bugliani, Paolo
La borsa di Ankara come hub finanziario di un'intera area
2011-01-01 Volpi, Alessandro
Le borse merci
2011-01-01 Bani, Elisabetta
Le borse merci
2008-01-01 Bani, Elisabetta
BORTEZOMIB (VEL) BASED REGIMENS IN MULTIPLE MYELOMA (MM) PATIENTS WITH RENAL IMPAIRMENT (RI): A PRELIMINARY RETROSPECTIVE ITALIAN MULTICENTER STUDY
2008-01-01 M., Gentile; 1 S., Ciolli; 2 M. T., Gentile M; Ciolli, S; Petrucci, Mt; Galimberti, Sara; Mele, G; Casulli, Af; Mannina, D; Piro, E; Morabito, F.
Bortezomib (VEL) Based Regimens in Multiple Myeloma (MM) Patients with Renal Impairment (RI): A Preliminary Retrospective Italian Multicenter Study
2008-01-01 Gentile, M; Ciolli, S; Petrucci, Mt; Galimberti, Sara; Mele, G; Casulli, Af; Mannina, D; Piro, E; Pinotti, G; Palmieri, S; Catalano, L; Callea, V; Offidani, M; Musto, P; Bringhen, S; Baldini, L; Tosi, P; Di Raimondo, F; Boccadoro, M; Palumbo, A; Cavo, M; Morabito, F.
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study
2015-01-01 Savlı, Hakan; Galimberti, Sara; Sünnetçi, Deniz; Canesastraro, Martina; Palumbo, Giuseppe; Nagy, Balint; Raimondo, Francesco Di; Petrini, Mario
Bortezomib and liposomal doxorubicin are highly effective in obtaining the best possible response before autologous transplant for multiple myeloma
2009-01-01 Buda, Gabriele; Orciuolo, E; Galimberti, Sara; Cecconi, N; Petrini, Mario
BORTEZOMIB COMBINED WITH HISTONE DEACETYLASE INHIBITOR ITF2357 OR ARSENIC TRIOXIDE EXERTS SYNERGISTIC ANTI-PROLIF- ERATIVE AND PRO-APOPTOTIC EFFECTS IN P39 CELL LINE: A POSSI- BLE NEW APPROACH TO HIGH-RISK MYELODYSPLASTIC SYNDROMES
2008-01-01 Galimberti, Sara; Canestraro, M; Savli, H; Palumbo, Ga; Nagy, B; Di Raimondo, F; Petrini, Mario
Bortezomib combined with histone deacetylase inhibitor ITF2357 or arsenic trioxide exerts aynergistic anti-proliferative and pro-apoptotic effect on P39 cells
2008-01-01 Savli, H.; Galimberti, Sara; Canestraro, M.; Nagy, B.; Palumbo, Ga; Petrini, Mario
Bortezomib inhibits T-cell function versus infective antigenic stimuli in a dose-dependent manner in vitro
2007-01-01 Orciuolo, E; Galimberti, Sara; Petrini, Mario
BORTEZOMIB IS ABLE TO INACTIVATE NF-KB AND DOWN-REGULATE WT1 GENE IN P39 CELL LINE: A POSSIBLE USE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES?
2008-01-01 Galimberti, Sara; Canestraro, M; Savli, H; Palumbo, Ga; Nagy, B; Di Raimondo, F; Petrini, Mario
Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo study
2008-01-01 Galimberti, Sara; Canestraro, Martina; Ciancia, Eugenio; Fazzi, R; Marasca, R; Petrini, Mario
Bortezomib with Thalidomide plus Dexamethasone Compared with Thalidomide plus Doxorubicin and Dexamethasone as Induction Therapy in Previously Untreated Multiple Myeloma Patients.
2013-01-01 Buda, G; Orciuolo, E; Carulli, Giovanni; Galimberti, Sara; Ghio, F; Cervetti, G; Pelosini, M; Petrini, Mario
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile